THE EFFECT OF CEFTRIAXONE ON THE ANAEROBIC BACTERIAL-FLORA AND THE BACTERIAL ENZYMATIC-ACTIVITY IN THE INTESTINAL-TRACT

被引:25
作者
WELLING, GW
MEIJERSEVERS, GJ
HELMUS, G
VANSANTEN, E
TONK, RHJ
DEVRIESHOSPERS, HG
VANDERWAAIJ, D
机构
[1] Laboratorium voor Medische Microbiologie, Rijksuniversiteit Groningen, Groningen, NL-9713 EZ
关键词
D O I
10.1007/BF01645354
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The normal flora of the intestinal tract, mainly consisting of anaerobic bacteria, protects the host against colonization by pathogenic microorganisms. Antimicrobial treatment with ceftriaxone may influence the colonic microflora and as a consequence, the protective effect. Ten healthy volunteers received 1 g of ceftriaxone intramuscularly for five days. This resulted in a significant decrease (p < 0.05) of the mean cultural counts (+/- SEM) of total anaerobes from 10.67 (0.11) (prior to treatment) to 9.02 (0.45) and 8.97 (0.46) at days 3 and 5, respectively (during treatment). After treatment (days 10 and 15-19), the cultural counts of anaerobes returned to 10.17 (0.16) and 10.44 (0.18), respectively. Bacterial enzymes may serve as an indicator of protective microflora. Beta-aspartylpeptidase and deoxycholate hydrolase activity was determined in faecal supernatants of the volunteers and compared with anaerobic culturing. Both enzymatic activities show a significant correlation with the total number of anaerobes present at day 3 of ceftriaxone treatment. At day 5 and 8 only beta-aspartylpeptidase showed significant correlations with cultural counts of total anaerobes, Bacteroides spp. or bifidobacteria. At day 15 to 19 (ten to 14 days after treatment) beta-aspartylpeptidase showed only a significant correlation with the number of Bacteroides spp. This indicates that changes in the indigenous bacterial flora during and shortly after treatment with ceftriaxone can be monitored by determination of beta-aspartylpeptidase. Recovery of the intestinal flora is difficult to assess in this manner.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 17 条
[1]   RO 13-9904, A LONG-ACTING BROAD-SPECTRUM CEPHALOSPORIN - INVITRO AND INVIVO STUDIES [J].
ANGEHRN, P ;
PROBST, PJ ;
REINER, R ;
THEN, RL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) :913-921
[2]  
[Anonymous], MICROB ECOL HLTH DIS
[3]   CEFTRIAXONE - RENAL AND BILIARY-EXCRETION AND EFFECT ON THE COLON MICROFLORA [J].
ARVIDSSON, A ;
ALVAN, G ;
ANGELIN, B ;
BORGA, O ;
NORD, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (03) :207-215
[4]  
BODEY GP, 1983, J INFECT DIS, V148, P8962
[5]  
Chen J. -S., 1977, ANAEROBE LAB MANUAL, VFourth
[6]   USE OF BETA-LACTAMASE-PRODUCING ANAEROBES TO PREVENT CEFTRIAXONE FROM DEGRADING INTESTINAL RESISTANCE TO COLONIZATION [J].
LEONARD, F ;
ANDREMONT, A ;
LECLERQ, B ;
LABIA, R ;
TANCREDE, C .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (02) :274-280
[7]   SHORT-CHAIN FATTY-ACID AND ORGANIC-ACID CONCENTRATIONS IN FECES OF HEALTHY-HUMAN VOLUNTEERS AND THEIR CORRELATION WITH ANAEROBE CULTURAL COUNTS DURING SYSTEMIC CEFTRIAXONE ADMINISTRATION [J].
MEIJERSEVERS, GJ ;
VANSANTEN, E ;
MEIJER, BC .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 (07) :698-704
[8]   EFFECT OF A SINGLE DOSE OF CEFOTAXIME OR CEFTRIAXONE ON HUMAN FECAL FLORA - A DOUBLE-BLIND-STUDY [J].
MICHEAHAMZEHPOUR, M ;
AUCKENTHALER, R ;
KUNZ, J ;
PECHERE, JC .
DRUGS, 1988, 35 :6-11
[9]  
NILSSONEHLE I, 1985, SCAND J INFECT DIS, V107, P77
[10]  
OWEN RW, 1986, MICROBIAL METABOLISM, P52